Veracyte | VCYT - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Agenus USD 14.4M 19.26M 2025-12
Agilent USD 353M 90M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
Bruker USD 10.2M 66.1M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Illumina USD 239M 17M 2026-03
Intrexon USD -60.84M 26.62M 2024-06
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Laboratory Of America USD 410.1M 28.1M 2026-03
Ligand Pharmaceuticals USD 60.33M 40.29M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Siemens EUR 2.57B 3M 2025-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Veracyte USD 19.08M 5.55M 2026-03
Waters USD 148M 122.52M 2026-03